# Reed'S, Inc.: financial statements, quarterly REED · NYSE · CIK 1140215 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/reed.md) · [Financials](/companies/reed/financials.md) · [Filings](/companies/reed/filings.md) · [Insiders](/companies/reed/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/reed/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [11.9](/filings/0001493152-24-045785.md) | [11.7 d](/filings/0001641172-25-001344.md) | [9.6](/filings/0001641172-25-010310.md) | [11.9](/filings/0001641172-25-023466.md) | [6.8](/filings/0001493152-25-020739.md) | [9.7 d](/filings/0001493152-26-012679.md) | [10.0](/filings/0001493152-26-022714.md) | [9.5](/filings/0001493152-26-037365.md) | [7.0](/filings/0001493152-25-020739.md) | [7.5 d](/filings/0001493152-26-012679.md) | [7.1](/filings/0001493152-26-022714.md) | [7.5](/filings/0001493152-26-037365.md) | | Cost of revenue | $m | [7.8](/filings/0001493152-24-045785.md) | [8.1 d](/filings/0001641172-25-001344.md) | [6.2](/filings/0001641172-25-010310.md) | [8.0](/filings/0001641172-25-023466.md) | [5.5](/filings/0001493152-25-020739.md) | [6.8 d](/filings/0001493152-26-012679.md) | [6.6](/filings/0001493152-26-022714.md) | [8.7](/filings/0001493152-26-037365.md) | [5.8](/filings/0001493152-25-020739.md) | [6.0 d](/filings/0001493152-26-012679.md) | [6.4](/filings/0001493152-26-022714.md) | [5.7](/filings/0001493152-26-037365.md) | | Gross profit | $m | [4.0](/filings/0001493152-24-045785.md) | [0.5 d](/filings/0001641172-25-001344.md) | [3.4](/filings/0001641172-25-010310.md) | [3.8](/filings/0001641172-25-023466.md) | [1.2](/filings/0001493152-25-020739.md) | [2.9 d](/filings/0001493152-26-012679.md) | [3.4](/filings/0001493152-26-022714.md) | [0.8](/filings/0001493152-26-037365.md) | [1.2](/filings/0001493152-25-020739.md) | [1.5 d](/filings/0001493152-26-012679.md) | [0.7](/filings/0001493152-26-022714.md) | [1.8](/filings/0001493152-26-037365.md) | | Operating income | $m | [(0.1)](/filings/0001493152-24-045785.md) | [(4.9) d](/filings/0001641172-25-001344.md) | [(0.7)](/filings/0001641172-25-010310.md) | [(0.7)](/filings/0001641172-25-023466.md) | [(3.1)](/filings/0001493152-25-020739.md) | [(3.7) d](/filings/0001493152-26-012679.md) | [(1.7)](/filings/0001493152-26-022714.md) | [(5.8)](/filings/0001493152-26-037365.md) | [(4.1)](/filings/0001493152-25-020739.md) | [(3.5) d](/filings/0001493152-26-012679.md) | [(6.2)](/filings/0001493152-26-022714.md) | [(4.1)](/filings/0001493152-26-037365.md) | | Interest expense | $m | [1.3](/filings/0001493152-24-045785.md) | [1.6 d](/filings/0001641172-25-001344.md) | [1.0](/filings/0001641172-25-010310.md) | [1.2](/filings/0001641172-25-023466.md) | [2.4](/filings/0001493152-25-020739.md) | [0.9 d](/filings/0001493152-26-012679.md) | [0.3](/filings/0001493152-26-022714.md) | [0.3](/filings/0001493152-26-037365.md) | [0.3](/filings/0001493152-25-020739.md) | [0.2 d](/filings/0001493152-26-012679.md) | [0.2](/filings/0001493152-26-022714.md) | [0.2](/filings/0001493152-26-037365.md) | | Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net income | $m | [(1.4)](/filings/0001493152-24-045785.md) | [(6.6) d](/filings/0001641172-25-001344.md) | [(1.7)](/filings/0001641172-25-010310.md) | [(3.2)](/filings/0001641172-25-023466.md) | [(4.2)](/filings/0001493152-25-020739.md) | [(4.1) d](/filings/0001493152-26-012679.md) | [(2.0)](/filings/0001493152-26-022714.md) | [(6.0)](/filings/0001493152-26-037365.md) | [(4.0)](/filings/0001493152-25-020739.md) | [(3.8) d](/filings/0001493152-26-012679.md) | [(6.5)](/filings/0001493152-26-022714.md) | [(4.3)](/filings/0001493152-26-037365.md) | | Diluted EPS | $ per share | [(0.34)](/filings/0001493152-24-045785.md) | not reported | [(0.40)](/filings/0001641172-25-010310.md) | [(0.77)](/filings/0001641172-25-023466.md) | [(4.91)](/filings/0001493152-25-020739.md) | not reported | [(0.27)](/filings/0001493152-26-022714.md) | [(0.78)](/filings/0001493152-26-037365.md) | [(0.48)](/filings/0001493152-25-020739.md) | not reported | [(0.55)](/filings/0001493152-26-022714.md) | [(0.36)](/filings/0001493152-26-037365.md) | | Basic EPS | $ per share | [(0.34)](/filings/0001493152-24-045785.md) | not reported | [(0.40)](/filings/0001641172-25-010310.md) | [(0.77)](/filings/0001641172-25-023466.md) | [(4.91)](/filings/0001493152-25-020739.md) | not reported | [(0.27)](/filings/0001493152-26-022714.md) | [(0.78)](/filings/0001493152-26-037365.md) | [(0.48)](/filings/0001493152-25-020739.md) | not reported | [(0.55)](/filings/0001493152-26-022714.md) | [(0.36)](/filings/0001493152-26-037365.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: not reported - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | period not labelled (2025-09-15) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [0.6](/filings/0001641172-25-001344.md) | [0.3](/filings/0001493152-24-020661.md) | [0.3](/filings/0001493152-24-031590.md) | [0.3](/filings/0001493152-24-045785.md) | [10.4](/filings/0001493152-26-012679.md) | [4.9](/filings/0001641172-25-010310.md) | [2.7](/filings/0001641172-25-023466.md) | [10.4](/filings/0001493152-26-012679.md) | [4.1](/filings/0001493152-25-020739.md) | [10.4](/filings/0001493152-26-037365.md) | [4.6](/filings/0001493152-26-022714.md) | [2.4](/filings/0001493152-26-037365.md) | | Current assets | $m | [17.8](/filings/0001641172-25-001344.md) | [18.2](/filings/0001493152-24-020661.md) | [17.7](/filings/0001493152-24-031590.md) | [14.1](/filings/0001493152-24-045785.md) | [23.3](/filings/0001493152-26-012679.md) | [22.7](/filings/0001641172-25-010310.md) | [21.9](/filings/0001641172-25-023466.md) | not reported | [18.1](/filings/0001493152-25-020739.md) | [21.5](/filings/0001493152-26-037365.md) | [16.8](/filings/0001493152-26-022714.md) | [13.7](/filings/0001493152-26-037365.md) | | Total assets | $m | [18.9](/filings/0001641172-25-001344.md) | [19.3](/filings/0001493152-24-020661.md) | [18.7](/filings/0001493152-24-031590.md) | [15.0](/filings/0001493152-24-045785.md) | [25.1](/filings/0001493152-26-012679.md) | [24.5](/filings/0001641172-25-010310.md) | [23.7](/filings/0001641172-25-023466.md) | not reported | [19.9](/filings/0001493152-25-020739.md) | [23.3](/filings/0001493152-26-037365.md) | [18.7](/filings/0001493152-26-022714.md) | [15.4](/filings/0001493152-26-037365.md) | | Current liabilities | $m | [27.2](/filings/0001641172-25-001344.md) | [25.0](/filings/0001493152-24-020661.md) | [37.1](/filings/0001493152-24-031590.md) | [37.0](/filings/0001493152-24-045785.md) | [17.7](/filings/0001493152-26-012679.md) | [19.0](/filings/0001641172-25-010310.md) | [21.2](/filings/0001641172-25-023466.md) | not reported | [16.4](/filings/0001493152-25-020739.md) | [13.4](/filings/0001493152-26-037365.md) | [15.2](/filings/0001493152-26-022714.md) | [16.1](/filings/0001493152-26-037365.md) | | Total liabilities | $m | [38.1](/filings/0001641172-25-001344.md) | [40.0](/filings/0001493152-24-020661.md) | [42.6](/filings/0001493152-24-031590.md) | [37.0](/filings/0001493152-24-045785.md) | [18.5](/filings/0001493152-26-012679.md) | [19.9](/filings/0001641172-25-010310.md) | [22.0](/filings/0001641172-25-023466.md) | not reported | [17.2](/filings/0001493152-25-020739.md) | [14.2](/filings/0001493152-26-037365.md) | [16.0](/filings/0001493152-26-022714.md) | [16.9](/filings/0001493152-26-037365.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [(19.2)](/filings/0001493152-26-012679.md) | [(20.7)](/filings/0001641172-25-023466.md) | [(23.8)](/filings/0001493152-25-020739.md) | [(22.0)](/filings/0001493152-25-020739.md) | [6.6](/filings/0001493152-26-037365.md) | [4.7](/filings/0001493152-26-037365.md) | [1.7](/filings/0001493152-26-037365.md) | not reported | [2.8](/filings/0001493152-25-020739.md) | [9.2](/filings/0001493152-26-037365.md) | [2.7](/filings/0001493152-26-037365.md) | [(1.5)](/filings/0001493152-26-037365.md) | - Cash and equivalents: us-gaap:Cash - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [(1,796) d](/filings/0001493152-24-045785.md) | [(182) d](/filings/0001641172-25-001344.md) | [(2,395)](/filings/0001641172-25-010310.md) | [(912) d](/filings/0001641172-25-023466.md) | [1,053 d](/filings/0001493152-25-020739.md) | [(3,870) d](/filings/0001493152-26-012679.md) | [(5,362)](/filings/0001493152-26-022714.md) | [(5,048) d](/filings/0001493152-26-037365.md) | [(2,820) d](/filings/0001493152-25-020739.md) | [(3,807) d](/filings/0001493152-26-012679.md) | [(5,844)](/filings/0001493152-26-022714.md) | [(2,170) d](/filings/0001493152-26-037365.md) | | Capital expenditure | $k | not reported | [1.0 d](/filings/0001641172-25-001344.md) | [16.0](/filings/0001641172-25-010310.md) | [12.0 d](/filings/0001641172-25-023466.md) | [23.0 d](/filings/0001493152-25-020739.md) | [101 d](/filings/0001493152-26-012679.md) | [73.0](/filings/0001493152-26-022714.md) | [22.0 d](/filings/0001493152-26-037365.md) | [96.0 d](/filings/0001493152-25-020739.md) | [81.0 d](/filings/0001493152-26-012679.md) | not reported | not reported | | Share repurchases | $k | [0.0 d](/filings/0001493152-23-040116.md) | [0.0 d](/filings/0001641172-25-001344.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [2.3](/filings/0001493152-23-040116.md) | [2.6](/filings/0001493152-24-020661.md) | [3.2](/filings/0001493152-24-031590.md) | [4.2](/filings/0001493152-24-045785.md) | [4.2](/filings/0001641172-25-010310.md) | [4.2](/filings/0001641172-25-023466.md) | [0.8](/filings/0001493152-25-020739.md) | [7.6](/filings/0001493152-26-022714.md) | [7.7](/filings/0001493152-26-037365.md) | [8.2](/filings/0001493152-25-020739.md) | [11.8](/filings/0001493152-26-022714.md) | [11.8](/filings/0001493152-26-037365.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 11,857,086 at 2026-08-07, from the cover of the [10-Q filed 2026-08-12](/filings/0001493152-26-037365.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.